Stay ahead of every shift in generics and biosimilars. Generics Bulletin brings you the latest updates that matter for the off-patent industry.
Aug 4 (Reuters) - India's Alembic Pharmaceuticals (ALEM.NS), opens new tab on Tuesday reported a 12.1% increase in first-quarter profit, driven by strong demand for generic drugs in its key U.S.
New Delhi: Amid a renewed push by the US President Donald Trump to impose tariffs on generic drugs, drugmakers in India are pushing for maintaining the status quo, arguing that remains unfeasible in ...
Teva is betting it has enough room to adequately prepare for steep tariffs the Trump administration plans to slap on generic drugs made outside the US. “We are at the table and we’ll be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results